Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine-Reference-Cited by-同舟云学术

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine

Published:2015-07-31 Issue:5 Volume:3 Page:e00160
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Gualdani Roberta¹,Tadini-Buoninsegni Francesco¹,Roselli Mariagrazia²,Defrenza Ivana²,Contino Marialessandra²,Colabufo Nicola Antonio²,Lentini Giovanni²

Affiliation:

1. Dipartimento di Chimica “Ugo Schiff”; Università di Firenze; via della Lastruccia 3 Sesto Fiorentino FI 50019 Italy

2. Dipartimento di Farmacia-Scienze del Farmaco; Università degli Studi di Bari “A. Moro”; via Orabona 4 Bari 70125 Italy

Funder

Ministero dell'Istruzione

dell'Universita' e della Ricerca

Ente Cassa di Risparmio di Firenze

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Reference65 articles.

1. Hemodialysis as an alternative treatment of mexiletine intoxication;Akinci;Am J Emerg Med,2011

2. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current;Barhanin;Nature,1996

3. Density-functional exchange-energy approximation with correct asymptotic behavior;Becke;Phys Rev A,1988

4. Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats;Brochu;Mol Pharmacol,2006

5. Facile, alternative route to lubeluzole, its enantiomer, and the racemate;Bruno;Chirality,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Mexiletine Administration Increases Sodium Current in Non-Diseased Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes;Biomedicines;2024-05-29

2. Dysregulation of N-terminal acetylation causes cardiac arrhythmia and cardiomyopathy;2023-07-03

3. Indications for mexiletine in the new ESC guidelines and beyond;Expert Opinion on Pharmacotherapy;2023-06-13

4. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome;Europace;2023-06

5. New in vitro multiple cardiac ion channel screening system for preclinical Torsades de Pointes risk prediction under the Comprehensive in vitro Proarrhythmia Assay concepta;The Korean Journal of Physiology & Pharmacology;2023-05-01